These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34056358)
1. Binding Selectivity of Inhibitors toward Bromodomains BAZ2A and BAZ2B Uncovered by Multiple Short Molecular Dynamics Simulations and MM-GBSA Calculations. Wang L; Wang Y; Yang Z; Xu S; Li H ACS Omega; 2021 May; 6(18):12036-12049. PubMed ID: 34056358 [TBL] [Abstract][Full Text] [Related]
2. Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains. Dalle Vedove A; Spiliotopoulos D; D'Agostino VG; Marchand JR; Unzue A; Nevado C; Lolli G; Caflisch A ChemMedChem; 2018 Jul; 13(14):1479-1487. PubMed ID: 29770599 [TBL] [Abstract][Full Text] [Related]
3. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B. Chen P; Chaikuad A; Bamborough P; Bantscheff M; Bountra C; Chung CW; Fedorov O; Grandi P; Jung D; Lesniak R; Lindon M; Müller S; Philpott M; Prinjha R; Rogers C; Selenski C; Tallant C; Werner T; Willson TM; Knapp S; Drewry DH J Med Chem; 2016 Feb; 59(4):1410-24. PubMed ID: 25799074 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the BAZ2B TAM domain. Feng Y; Chen S; Zhou M; Zhang J; Min J; Liu K Heliyon; 2022 Jul; 8(7):e09873. PubMed ID: 35865993 [TBL] [Abstract][Full Text] [Related]
5. Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining. Dalle Vedove A; Cazzanelli G; Corsi J; Sedykh M; D'Agostino VG; Caflisch A; Lolli G ACS Bio Med Chem Au; 2021 Dec; 1(1):5-10. PubMed ID: 36147311 [TBL] [Abstract][Full Text] [Related]
6. Binding selectivity of inhibitors toward the first over the second bromodomain of BRD4: theoretical insights from free energy calculations and multiple short molecular dynamics simulations. Wang Y; Wu S; Wang L; Yang Z; Zhao J; Zhang L RSC Adv; 2020 Dec; 11(2):745-759. PubMed ID: 35423696 [TBL] [Abstract][Full Text] [Related]
7. Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B. Drouin L; McGrath S; Vidler LR; Chaikuad A; Monteiro O; Tallant C; Philpott M; Rogers C; Fedorov O; Liu M; Akhtar W; Hayes A; Raynaud F; Müller S; Knapp S; Hoelder S J Med Chem; 2015 Mar; 58(5):2553-9. PubMed ID: 25719566 [TBL] [Abstract][Full Text] [Related]
8. Discovery of BAZ2A bromodomain ligands. Spiliotopoulos D; Wamhoff EC; Lolli G; Rademacher C; Caflisch A Eur J Med Chem; 2017 Oct; 139():564-572. PubMed ID: 28837921 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses. Chen J; Liu X; Zhang S; Chen J; Sun H; Zhang L; Zhang Q Phys Chem Chem Phys; 2020 Jan; 22(4):2262-2275. PubMed ID: 31917380 [TBL] [Abstract][Full Text] [Related]
11. Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing. Dalle Vedove A; Cazzanelli G; Batiste L; Marchand JR; Spiliotopoulos D; Corsi J; D'Agostino VG; Caflisch A; Lolli G ACS Med Chem Lett; 2022 Sep; 13(9):1434-1443. PubMed ID: 36105334 [TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanism of Binding Selectivity of Inhibitors toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions. Chen J; Wang J; Yin B; Pang L; Wang W; Zhu W ACS Chem Neurosci; 2019 Oct; 10(10):4303-4318. PubMed ID: 31545898 [TBL] [Abstract][Full Text] [Related]
13. Revealing binding selectivity of inhibitors toward bromodomain-containing proteins 2 and 4 using multiple short molecular dynamics simulations and free energy analyses. Wang LF; Wang Y; Yang ZY; Zhao J; Sun HB; Wu SL SAR QSAR Environ Res; 2020 May; 31(5):373-398. PubMed ID: 32496901 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of inhibitor bindings to A-FABP deciphered by using molecular dynamics simulations and calculations of MM-GBSA. Yin YY; Zhao J; Zhang LL; Xu XY; Liu JQ SAR QSAR Environ Res; 2021 Apr; 32(4):293-315. PubMed ID: 33655818 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and cellular insights into the Baz2B protein, a non-catalytic subunit of the chromatin remodeling complex. Breindl M; Spitzer D; Gerasimaitė R; Kairys V; Schubert T; Henfling R; Schwartz U; Lukinavičius G; Manelytė L Nucleic Acids Res; 2024 Jan; 52(1):337-354. PubMed ID: 38000389 [TBL] [Abstract][Full Text] [Related]
16. Deciphering Selectivity Mechanism of BRD9 and TAF1(2) toward Inhibitors Based on Multiple Short Molecular Dynamics Simulations and MM-GBSA Calculations. Wang L; Wang Y; Yu Y; Liu D; Zhao J; Zhang L Molecules; 2023 Mar; 28(6):. PubMed ID: 36985555 [TBL] [Abstract][Full Text] [Related]
17. Revealing binding selectivity of ligands toward murine double minute 2 and murine double minute X based on molecular dynamics simulations and binding free energy calculations. Shi S; Sui K; Liu W; Lei Y; Zhang S; Zhang Q J Biomol Struct Dyn; 2020 Oct; 38(17):5081-5094. PubMed ID: 31755361 [TBL] [Abstract][Full Text] [Related]
18. High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography. Lolli G; Caflisch A ACS Chem Biol; 2016 Mar; 11(3):800-7. PubMed ID: 26942307 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of inhibitor bindings to bromodomain-containing protein 9 explored based on molecular dynamics simulations and calculations of binding free energies. Wang Y; Wang LF; Zhang LL; Sun HB; Zhao J SAR QSAR Environ Res; 2020 Feb; 31(2):149-170. PubMed ID: 31851834 [TBL] [Abstract][Full Text] [Related]